Analysts have been busy revising targets across tech, industrials, and healthcare this week.
Intel drew fresh attention as consensus target prices ticked up to $79.05. The chipmaker carries a split analyst view — 5 sells against 13 holds and 13 buys. Sentiment is improving despite ongoing structural pressures at the firm.
AMD also saw upward target revisions, with the average consensus price rising to $307.50. Analysts remain broadly bullish, with 35 buy ratings against just no sells in the current count.
A notable new initiation landed on Solventum, the $11.6B healthcare spinoff from 3M. Analysts issued a new recommendation with a consensus target of $84.08. The stock sits in "Hold" territory, with 2 sells, 6 holds, and 6 buys — a divided street still sizing up the standalone business.
Cardinal Health was the standout downgrade. The consensus moved lower, with the average target slipping to $247.13. It remains well-liked with 15 buys, but the target cut signals some caution after a strong run.
In HVAC and industrials, Trane Technologies and both saw target upgrades — reflecting solid earnings and resilient demand for climate systems. also gained a small target bump to $530.45.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
